Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
112.69
+0.59 (+0.53%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
August 23, 2024
Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.
Via
MarketBeat
Exposures
Product Safety
Abbott Laboratories Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
August 22, 2024
Via
Benzinga
Abbott Laboratories, Nu Holdings And More On CNBC's 'Final Trades'
August 22, 2024
Abbott Laboratories has a strong pipeline and the stock is starting to move, according to Karen Firestone of Aureus Asset Management.
Via
Benzinga
Looking for Safe Dividend Income? These 3 Stocks Have Rock-Solid Payouts.
August 17, 2024
These stocks pay above-average yields, and their dividend income could rise higher in the future.
Via
The Motley Fool
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
August 12, 2024
An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver.
Via
The Motley Fool
Abbott Laboratories's Options Frenzy: What You Need to Know
July 26, 2024
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
July 26, 2024
Via
Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
All of these stocks can provide steady income to retired investors.
Via
The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
August 09, 2024
EQNX::TICKER_START (NYSE:OGEN),(NYSE:ABT),(NASDAQ:BIIB),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
Via
FinancialNewsMedia
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
3 Dividend Growth Stocks to Buy Hand Over Fist in August
August 07, 2024
There are blue-chip bargains paying large and growing dividends in the healthcare space.
Via
The Motley Fool
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Healthcare and biopharma show nice gains in a volatile week.
Via
Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
Recent market pressure could worsen, but that won't stop these successful businesses from raising their dividend payouts.
Via
The Motley Fool
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
August 03, 2024
Dividend stocks are great; cheap dividend stocks are better.
Via
The Motley Fool
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
August 02, 2024
Abbott Laboratories' growth rate may look comparable to Johnson & Johnson's, but in the long run it could become much higher.
Via
The Motley Fool
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via
InvestorPlace
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
July 31, 2024
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Healthcare Stocks Are Coming On Strong In July Led By Biotech
July 29, 2024
The biotech rally gained momentum in July with rotation out of technology stocks.
Via
Talk Markets
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
July 29, 2024
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.
Via
InvestorPlace
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
July 29, 2024
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.
Via
InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
July 29, 2024
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.
Via
InvestorPlace
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.
Via
InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 29, 2024
Via
Benzinga
US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap'
July 29, 2024
Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s...
Via
Benzinga
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula
July 29, 2024
This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Is Beaten-Down Dexcom Stock a Buy on the Dip?
July 29, 2024
The market may have overreacted to a disappointing earnings report.
Via
The Motley Fool
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via
Benzinga
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
July 26, 2024
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today.
Via
InvestorPlace
Better Buy: Abbott Laboratories vs. Intuitive Surgical
July 26, 2024
The medical technology business has been good for both companies, but which is right for your portfolio?
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.